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Introduction
Tetrahydrobiopterin (BH
4
) is a cofactor of the aromatic 
amino acid hydroxylases, the nitric oxide synthases 
(NOS) and the alkylglycerol monooxygenase (Werner 
et al., 2011). BH
4
 is easily oxidized to 7,8-dihydrobiopterin 
(BH
2
) which may be further oxidized to biopterin. BH
4
 is 
essential for the production of nitric oxide, an endothe-
lial vasorelaxing factor, by NOS and may hence serve as 
a biomarker of endothelial dysfunction. While BH
2
 may 
bind to NOS just like BH
4
 (Vásquez-Vivar et al., 2002; 
Crabtree et al., 2008), it does not support the formation 
of nitric oxide (Presta et al., 1998) and instead superoxide 
is formed (Vásquez-Vivar et al., 2002). Studies have sug-
gested that the ratio of BH
4
 to BH
2
 correlates better with 
endothelial function than the absolute concentration of 
BH
4
 (Noguchi et al., 2011; Crabtree et al., 2008; Takeda 
et al., 2009; Kar & Kavdia, 2011). Consequently, appropri-
ate stabilization and analysis of both BH
4
 and BH
2
 is a 
prerequisite.
BH
4
 and BH
2
 in plasma are determined either directly 
or indirectly by high-performance liquid chromatography 
(HPLC) employing electrochemical (Powers et al., 1988), 
fluorescence (Fukushima & Nixon, 1980; Mochizuki 
et al., 2005) or mass spectrometry detection (Feillet et al., 
2008). Prior to analysis plasma proteins are removed; a 
step most often accomplished by acid precipitation. It 
has long been known that the auto-oxidation of BH
4
 pro-
ceeds more rapidly at higher pH (Blair & Pearson, 1973; 
Pearson & Blair, 1975; Pearson, 1974; Berka et al., 2004) 
and at pH <3 the rate is markedly reduced (Lyudnikova 
et al., 2009). However, when it comes to BH
2
, its stability 
at the low pH used to precipitate proteins is less well-
studied. Some authors observed degradation of BH
2
 in 
acid (Katoh & Akino, 1966; Schircks et al., 1978) and at 
neutral pH (Fukushima & Nixon, 1979), whereas others 
have found a high stability of BH
2
 in aqueous solution at 
neutral and acidic pH (Dántola et al., 2008; Maharaj et al., 
1990; Heales et al., 1988).
Importantly, however, the previous stability studies 
of BH
4
 and BH
2
 have been performed at micromolar 
or higher concentration whereas the physiologically 
relevant concentration range is nanomolar. Also, 
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the studies have not been performed using the acids 
commonly used for protein precipitation.
Here, we present the results of a stability study of BH
4
 
and BH
2
 at nanomolar concentration in the presence of 
three acids (meta-phosphoric acid (MPA), perchloric 
acid (PA), and trichloroacetic acid (TCA)) commonly 
used for plasma protein precipitation. We also report on 
the stability at neutral pH and examined whether antioxi-
dants may affect the stability of BH
4
 and BH
2
 in aqueous 
solution. Finally, we have studied the stability of biopter-
ins in blood under various clinically relevant conditions.
Methods
Materials
7,8-Dihydro-l-biopterin, 5,6,7,8-tetrahydro-l-biopterin 
dihydrochloride and l-biopterin were from Shircks 
Laboratories (Jena, Switzerland). Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP), disodium ethylene-
diaminetetraacetatedihydrate (EDTA), acetic acid, TCA, 
citric acid monohydrate, methanol, potassium iodide, 
hydrochloric acid, sodium hydroxide, potassium dihy-
drogen phosphate, dipotassium hydrogen phosphate 
and sodium dihydrogen phosphate monohydrate were 
purchased from VWR – Bie&Berntsen A/S (Herlev, 
Denmark). Ammonium acetate, trisodium citrate dihy-
drate, 1,4-dithioerythritol (DTE), MPA, PA (20%), iodine 
and disodium hydrogen phosphate dihydrate were 
obtained from Sigma-Aldrich (Brøndby, Denmark). All 
solutions were made in Milli-Q water.
Analysis
The HPLC system consisted of an Agilent (Hørsholm, 
Denmark) 1100 thermostatted autosampler, an Agilent 
1200 binary pump, an Agilent 1200 fluorescence detector 
(excitation wavelength 275 nm and emission wavelength 
442 nm), and an Ultimate 3000 column compartment 
from Dionex (Hvidovre, Denmark). Upstream of the fluo-
rescence detector was placed an ESA-conditioning cell 
(5021A) running at 400 mV (controlled by a CouloChem 
II detector from ESA (Hvidovre, Denmark)) in order to 
oxidize BH
2
 to the more strongly fluorescent biopterin 
(only used when analyzing the stability of BH
2
).
For the analysis of BH
4
 and BH
2
 a Symmetry C8 col-
umn (250 × 4.6 mm, 5 µm) from Waters (Hedehusene, 
Denmark) was used. The samples were eluted with (1) 
92% aqueous buffer containing 50 µM EDTA and 50 mM 
ammonium acetate-acetic acid buffer at pH 5.1 and (2) 
8% methanol. The column was thermostatted at 30°C and 
the eluent flow was 1 ml/min.
A Synergi Polar column (150 × 4.6 mm, 4 µm) and a 
guard column (4 × 3.0 mm) from Phenomenex (Værløse, 
Denmark) were used for analysis of blood samples. The 
samples were eluted with (1) 95% aqueous buffer contain-
ing 100 µM EDTA and 50 mM potassium phosphate buffer 
at pH 6.73 and (2) 5% methanol for 4 min followed by a 
gradient to 90% B to clean the column. The column was 
thermostatted at 35°C and the eluent flow was 1 ml/min.
Customarily, 350 nm is used for excitation in biop-
terin analysis. However, using an excitation wavelength 
of 275 nm increases the signal around 3 times, thereby 
increasing the limits of detection and quantitation. The 
drawback of using 275 nm is the possibility of exciting 
more compounds, thereby increasing the number of 
detected compounds and the possibility of overlapping 
peaks in the chromatogram. With our method the separa-
tion of peaks was good when exciting at 275 nm in blood 
samples and actually did not improve when exciting at 
350 nm. Therefore, 275 nm was used throughout.
BH
2
A 20 µM stock solution of BH
2
 in Milli-Q water was stored 
at –80°C and used within 2 weeks. The stock solution was 
diluted to 20 nM in 50 mM phosphate buffer at pH 7.4 
(with or without DTE or TCEP) or 50 mM citrate buffers 
at pH 3.0, 4.0, 5.0, and 6.0 (with or without DTE or TCEP). 
Because TCEP is an acid, the pH of the buffer solutions 
containing TCEP was adjusted with sodium hydroxide to 
give the same pH as the buffer without TCEP. Solutions 
containing 20 nM of BH
2
 in 5% MPA (with or without 
DTE or TCEP) or 5% TCA (with or without DTE or TCEP) 
or 3% PA (with or without DTE or TCEP), which are the 
commonly used concentrations of acid used for protein 
precipitation, were also analyzed.
Samples were left in the thermostatted autosampler at 
25°C in plastic vials until subjected to analysis. A new vial 
was used for each injection of 10 µl.
BH
4
A 200 µM stock solution of BH
4
 in Milli-Q water containing 
either 6.5 mM DTE or TCEP was stored at –80°C and used 
within 2 weeks. The stock solution was diluted to 20 nM 
in 50 mM phosphate buffer at pH 7.4 (containing either 
DTE or TCEP). Because TCEP is an acid, the pH of the buf-
fer solution containing TCEP was adjusted with sodium 
hydroxide to give the same pH as the buffer without TCEP. 
Solutions containing 20 nM of BH
4
 in 5% MPA (containing 
either DTE or TCEP) or 5% TCA (containing either DTE or 
TCEP) or 3% PA (containing either DTE or TCEP) were also 
analyzed. The samples were wrapped in tin foil and stored 
at 25°C in a thermostatted oven. Aliquots were drawn at 
intervals and analyzed according to the iodine oxidation 
method of Fukushima and Nixon (1980) employing the 
same eluent and column as for the BH
2
 analysis.
Blood samples
Blood was drawn from a male volunteer in 4 ml K3E BD 
Vacutainer tubes to which were added 100 µl 4% DTE 
yielding a final concentration of DTE of around 0.1%. 
Blood was divided in three aliquots. One aliquot was left 
in a thermostatic oven at 25°C in the vacutainer. A sec-
ond aliquot was centrifuged, the plasma separated and 
placed in the oven. A third aliquot was centrifuged and 
the plasma divided into three. The three fractions were 
added TCA, MPA, or PA: to four volumes of plasma was 
added one volume of 1 M TCA, 25% MPA or 15% PA. The 
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samples were spun and the supernatant stored in the 
oven together with the other samples.
Aliquots were taken regularly and analyzed by the 
method of Fukushima and Nixon (1980). Blood was 
centrifuged, plasma separated and proteins precipitated 
with TCA, MPA, or PA before oxidation with iodine. 
Plasma was added TCA, MPA, or PA.
Results
BH
2
Regardless of pH, the major detected degradation prod-
uct of BH
2
 was biopterin. Mass balance analysis showed 
that biopterin could not be the only compound formed 
from degradation of BH
2
 (see below), however, biop-
terin was the only detectable degradation product of 
significance. Figure 1A shows the chromatogram of BH
2
 
in phosphate buffer after 108 h. The peak at 5 min is BH
2
 
whereas the peak at 5.36 min is biopterin. A number of 
very small peaks could also be discerned. It was not the 
purpose of this study to precisely elucidate the reaction 
mechanisms and determine all degradation products.
Degradation of BH
2
 followed first-order kinetics, i.e. 
exponential loss of BH
2
 in all solutions examined. The 
first-order rate constants are presented in Table 1. These 
rate constants are in reality not true first-order rate con-
stants, as they depend on pH and may also depend on 
oxygen concentration (see Discussion section). However, 
the concentration of hydrogen ions can be considered to 
be constant over time in the solutions, either because the 
solutions are buffered or because of a large surplus of 
hydrogen ions compared to BH
2
 in the acidic solutions. 
Likewise, the concentration of oxygen is much higher 
than the concentration of BH
2
 and can be considered 
to remain constant throughout the course of reaction as 
well.
BH
2
 is rather stable in solution with half-lives of >2.5 h 
regardless of pH. However, pH is not the only determi-
nant of BH
2
 stability. Somewhat surprisingly, the rate of 
degradation of BH
2
 is lower in PA than in TCA and MPA, 
despite the lower pH and despite the fact that PA, besides 
being a strong acid, is also an oxidizing acid that poten-
tially could oxidize BH
2
. The rate of degradation is also 
higher in MPA than in TCA despite the higher pH in the 
former. Comparing the phosphate buffer at pH 7.4 and 
the citrate buffer at pH 6.0, the higher pH of the phos-
phate buffer leads to an increase in reaction rate rather 
than a decrease.
From the rate constants in Table 1, it is clear that the 
rate of degradation of BH
2
 is not proportional to the 
hydrogen ion concentration, but the (apparent) first-
order rate constant shows a weaker dependence on acid-
ity. Looking at the citrate buffers alone, the first-order rate 
constants could be shown to perfectly follow a second-
order polynomial expression in the pH range 3–6:
k = ×( ) × + 1 pH  12 pH 38 BH alone2 20 0 0 0. . . ( )−
k = ×( ) × + 55 pH 76 pH 26 BH with TCEP2 20 00 0 0 0. . . ( )−
k = ×( ) × + 59 pH 86 pH 31 BH with DTE2 20 00 0 0 0. . . ( )−
These mathematical relationships indicate that the 
mechanism of degradation is not merely a matter of pro-
tonation of BH
2
, followed by oxidation of the protonated 
BH
2
, the pK
a
 of which has been determined to be 2.56 
(Maharaj et al., 1990).
Since the major pathway of degradation of BH
2
 in 
neutral and acidic solution is oxidation, it is relevant to 
examine if antioxidants could stabilize BH
2
. DTE and the 
closely related dithiothreitol (DTT) are often used to sta-
bilize BH
4
 in plasma before analysis. A concentration of 
0.1%, corresponding to 6.5 mM, is commonly employed 
at which concentration DTT has been found to be able 
to stabilize BH
4
 in plasma for a few hours (Fekkes & 
Voskuilen-Kooijman, 2007). TCEP is an antioxidant used 
primarily for reducing disulfide bonds. However, it has 
been succesfully used for stabilizing ascorbic acid in 
solution (Lykkesfeldt, 2000) and we therefore decided 
to test its suitability with respect to biopterins. The same 
concentration, i.e. 6.5 mM, of TCEP was used throughout.
Neither of the two antioxidants was very effective in 
protecting BH
2
 from oxidation (Table 1). In solutions of 
the three acids, both antioxidants conferred the same 
level of modest protection to BH
2
. As far as DTE goes, this 
is somewhat surprising, as the antioxidative capability is 
considered to be lost at low pH. In citrate and phosphate 
buffers, TCEP does provide some protection whereas DTE 
does not. In fact, DTE seems to have a pro-oxidant effect at 
Figure 1. Chromatograms of dihydrobiopterin (BH
2
) in phosphate 
buffer (pH 7.4) (A) without and with (B) dithioerythritol (DTE) after 
108 h.
B
io
m
ar
ke
rs
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
D
an
m
ar
ks
 V
et
er
in
ae
r &
 Jo
rd
br
ug
sb
ib
lio
te
k 
on
 0
1/
18
/1
3
Fo
r p
er
so
na
l u
se
 o
nl
y.
58 A. Mortensen and J. Lykkesfeldt
  Biomarkers
pH 4, 5, and 7.4 (Table 1). Besides affecting the rate of deg-
radation of BH
2
, DTE also affected the reaction pathway. 
In Figure 1B it can be seen that DTE caused formation 
of a compound eluting at 4.73 min. This compound was 
observed in citrate and phosphate buffers but not in the 
more acidic solutions. It was virtually absent in solutions 
of BH
2
 without antioxidants and in solutions with TCEP. 
The nature of this compound remains to be established. 
At pH 7.4 after 108 h of autoxidation, BH
2
 and biopterin 
accounted for 100% of the added BH
2
. With TCEP, BH
2
, 
and biopterin also accounted for the majority of species 
present (around 94%) after 108 h. However, in the pres-
ence of DTE at pH 7.4, the concentration of BH
2
 and biop-
terin only amounted to 30% each, that is, 40% of the initial 
amount of BH
2
 had been converted to compound(s) other 
than biopterin, one of them the species at 4.73 min. In 
general, regardless of pH more BH
2
 could be recovered 
as either BH
2
 or biopterin at the end of the reaction if no 
antioxidant was used, whereas DTE gave a low recovery 
of BH
2
 as either BH
2
 or biopterin; TCEP was in between 
(Table 2). Also, with the citrate buffers a lower amount of 
BH
2
 was recovered as either BH
2
 or biopterin at low pH 
compared to high. However, phosphate buffer provided 
a lower recovery of BH
2
 as either BH
2
 or biopterin than 
did citrate buffer at pH 6 once again demonstrating that 
pH is not the only factor influencing conversion of BH
2
. 
A particularly low recovery was observed with MPA (43% 
with antioxidant and 54% without). Besides the small 
peak at 4.73 min observed at high pH with DTE (Figure 1), 
no other peaks (except for very small ones) than BH
2
 and 
biopterin were detected meaning that BH
2
 was converted 
into nonfluorescent compounds.
BH
4
The stability of BH
4
 in the three acids was also studied. 
Because of its instability, BH
4
 stability was only exam-
ined in the presence of antioxidant—in clinical settings, 
DTE or DTT is routinely added to the sample to avoid 
degradation.
BH
4
 was remarkably stable in all three acids with DTE 
or TCEP. Over a period of 48 h no statistically signifi-
cant degradation took place with one exception: BH
4
 in 
TCA with DTE (p < 0.001, linear regression) (Figure 2). 
From the data, it was not evident whether the degrada-
tion was zero- or first-order: zero-order rate constant 
0.094 ± 0.006 nM/h (R2 = 0.977) or first-order rate constant 
0.0053 ± 0.0004 h–1 (R2 = 0.973). Concomitantly, the level 
of oxidized biopterins (BH
2
 and biopterin) rose. Another 
interesting finding was that the response of BH
4
 was 
around 20% lower in MPA than in TCA and PA, regardless 
of whether DTE or TCEP was used. This lower response 
did not seem to be due to degradation as the concentra-
tion of BH
4
 in MPA did not change with time (Figure 2).
The stability of BH
4
 in phosphate buffer at pH 7.4 was 
also studied. In Figure 3 is shown the degradation of BH
4
 
as a function of time. In contrast to the situation at low pH, 
BH
4
 stability at pH 7.4 was markedly reduced. Apparently, 
the degradation of BH
4
 with DTE followed zero-order 
kinetics with a rate constant of 0.254 ± 0.013 nM/h, while 
Table 1. First-order rate constants (h–1) for degradation of BH
2
.
Acid/buffer pH BH
2
BH
2
 + TCEP BH
2
 + DTE
PA 0.75 0.0943 ± 0.0022 0.0786 ± 0.0011 0.0828 ± 0.0013
TCA 0.89 0.2112 ± 0.0038 0.1475 ± 0.0013 0.1464 ± 0.0011
MPA 1.51 0.2701 ± 0.0058 0.2434 ± 0.0023 0.2441 ± 0.0017
Citrate 3.0 0.1050 ± 0.0034 0.0814 ± 0.0004 0.1037 ± 0.0007
Citrate 4.0 0.0496 ± 0.0011 0.0454 ± 0.0005 0.0587 ± 0.0007
Citrate 5.0 0.0216 ± 0.0009 0.0170 ± 0.0003 0.0273 ± 0.0004
Citrate 6.0 0.0061 ± 0.0005 0.0028 ± 0.0003 0.0060 ± 0.0003
Phosphate 7.4 0.0087 ± 0.0008 0.0050 ± 0.0003 0.0112 ± 0.0003
BH
2
, dihydrobiopterin; DTE, 1,4-dithioerythritol; TCEP, tris(2-carboxyethyl)phosphine hydrochloride.
Table 2. Percent recovery of BH
2
 as either BH
2
 or biopterin at the 
end of the degradation.
Without antioxidant TCEP DTE
PA 71 67 71
TCA 81 66 66
MPA 54 43 43
Citrate pH 3 69 61 53
Citrate pH 4 79 70 54
Citrate pH 5 86 80 57
Citrate pH 6 100 99 83
Phosphate pH 7.4 100 94 61
BH
2
, dihydrobiopterin; DTE, 1,4-dithioerythritol; MPA, meta-
phosphoric acid; PA, perchloric acid; TCA, trichloroacetic acid; 
TCEP, tris(2-carboxyethyl)phosphine hydrochloride.
Figure 2. Degradation of tetrahydrobiopterin (BH
4
) in 
trichloroacetic acid (TCA) with dithioerythritol (DTE) (closed 
square) and in meta-phosphoric acid (MPA) with DTE (closed 
circle).
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the degradation in the presence of TCEP was first-order 
with a rate-constant of 0.145 ± 0.025 h–1.
Blood
Stability of blood was only studied with DTE as the 
prior experiments with BH
4
 had indicated that DTE was 
a better antioxidant than TCEP at pH 7.4. Regardless 
in which state blood samples were left at 25°C (whole 
blood, plasma or acidified plasma) and which acid was 
used for precipitation, no significant changes in BH
4
 or 
BH
2
 levels or the BH
2
-to-BH
4
 ratio over time were found. 
However, there were considerable differences in ana-
lytical response or recovery. The data were analyzed by 
two-way ANOVA using the acid and pretreatment of the 
blood sample as factors followed by Tukey’s post hoc test 
of planned comparisons. Table 3 shows the results with 
respect to acid used for precipitation. BH
4
 levels were 
~30–35% lower when precipitating proteins with MPA 
compared to the two other acids. TCA gave a slightly 
higher BH
4
 level than did PA. The situation was reversed 
when it came to the oxidized biopterins BH
2
, and biop-
terin: here MPA gave the highest level and TCA the low-
est level. Despite the higher level of BH
2
 + biopterin with 
MPA, it was not enough to offset the lower level of BH
4
 
and the total level of biopterins was significantly reduced 
compared to the two other acids; there was no difference 
between TCA and PA (Table 3).
When it comes to pretreatment of the samples, BH
4
 
levels were unaffected by how the blood samples were 
stored (Table 4). BH
2
 + biopterin levels, however, were 
slightly lower in the acid-precipitated samples than in 
whole blood and plasma samples. This affected the BH
2
-
to-BH
4
 ratio but not the level of total biopterins.
Discussion
In the present study, we wanted to investigate the stabil-
ity of BH
4
 and BH
2
 both under controlled aqueous con-
ditions and more clinically relevant conditions in order 
to provide a rational basis for recommending a standard 
stabilization procedure which adequately preserves the 
in vivo equilibrium of the analytes.
With regard to BH
2
, the present study demonstrates—in 
line with previous findings—that BH
2
 is degraded in aque-
ous solution at neutral and acidic pH, the major degrada-
tion product being biopterin. Katoh and Akino observed 
that BH
2
 in 0.5 N sulfuric acid (stored overnight at –20°C) 
was oxidized to biopterin and to a lesser extent dehydrox-
ylated to form deoxysepiapterin (Katoh & Akino, 1966). 
Likewise, BH
2
 in 25% acetic acid was found to be degraded 
to a number of compounds, the major compound being 
biopterin even when the reaction was carried out under 
nitrogen for 20 min at 60°C (Schircks et al., 1978). Formation 
of biopterin was believed to be due to intermolecular redox 
reactions. Fukushima and Nixon (1979) studied the autoxi-
dation of BH
2
 at pH 4, 6, and 7.5. After 2–3 days of autoxi-
dation at room temperature they found that biopterin was 
the major product with minor amounts of sepiapterin, 
deoxysepiapterin, and xanthopterin. None of these studies 
looked at the kinetics of degradation of BH
2
.
However, other studies failed to observe any degra-
dation. Thus, Maharaj et al. found that the absorption 
spectrum of BH
2
 did not change with time (time span 
not indicated) at low pH (0.15 N and 5 N HCl) indicat-
ing that BH
2
 was stable under these conditions (Maharaj 
et al., 1990). The lack of any observable changes may have 
been due to a too short period of observation. Likewise, 
Table 3. Plasma levels of biopterins with respect to acidification strategy.
BH
4
/nM BH
2
 + Biopterin/nM Total/nM BH
2
–BH
4
 ratio
TCA 24.9 ± 1.0a 9.2 ± 1.3a 34.1 ± 1.0a 0.37 ± 0.06a
MPA 16.3 ± 1.3b,*** 12.6 ± 1.3b,*** 28.9 ± 1.5b,*** 0.78 ± 0.11b,***
PA 23.1 ± 1.1c,*** 10.2 ± 0.9c,* 33.3 ± 0.9a 0.44 ± 0.05c,*
Numbers bearing different superscript lettering are significantly different.
BH
2
, dihydrobiopterin; BH
4
, tetrahydrobiopterin; MPA, meta-phosphoric acid; PA, perchloric acid; TCA, trichloroacetic acid.*p < 0.05, ***p < 
0.001 compared to TCA.
Table 4. Bench stability (25°C) of biopterins under various conditions.
BH
4
/nM BH
2
 + Biopterin/nM Total/nM BH
2
–BH
4
 ratio
Blood 21.0 ± 4.0 11.0 ± 2.1a 32.1 ± 2.3 0.57 ± 0.23a
Plasma 21.5 ± 3.9 11.0 ± 1.6a 32.4 ± 2.6 0.54 ± 0.19a,b
Acid-precipitated 21.7 ± 4.0 10.0 ± 1.7b * 31.8 ± 3.0 0.49 ± 0.17b *
Numbers within a column bearing different superscript lettering are significantly different.
BH
2
, dihydrobiopterin; BH
4
, tetrahydrobiopterin. *p < 0.05.
Figure 3. Degradation of tetrahydrobiopterin (BH
4
) in phosphate 
buffer (pH 7.4) with dithioerythritol (DTE) (closed circle) and 
tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (closed 
square).
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Heales et al. did not observe any degradation of BH
2
 at 
pH 1.6, 5.3, and 7.6 when autoxidized for 30 min (Heales 
et al., 1988). As shown here, BH
2
 is only degraded to a 
small extent in 30 min. Davis et al. observed no degrada-
tion of BH
2
 for up to 150 min at pH 6.8–8.2 (Davis et al., 
1988), which is in line with our results showing little deg-
radation during this short-time span. On the other hand, 
Dántola et al. followed the degradation of BH
2
 at neutral 
pH at 25°C for 2 days and observed very little degrada-
tion (Dántola et al., 2008). They determined a first-order 
rate constant of degradation of BH
2
 of 0.0004 h–1 (this rate 
constant should be regarded with some caution as the 
reaction was only followed for 48 h, during which very lit-
tle reaction would have taken place), which is at least an 
order of magnitude lower than our results at pH 6.0 and 
7.4. They did not use buffers but adjusted pH to 7.0 using 
hydrochloric acid or aqueous sodium hydroxide. In com-
bination with our results, this could indicate that buffers 
actually enhance the degradation of BH
2
, in line with our 
observations that the rate of degradation depends on the 
nature of the buffer/acid and not only on pH. That the 
nature of the buffer also plays a role in the degradation of 
BH
2
 (and BH
4
), has been demonstrated previously where 
it was found, that the degradation product profile was 
different in succinate, phosphate and Tris buffer at the 
same pH (Fukushima & Nixon, 1979).
With regard to BH
4
, our results showed an increased 
stability of BH
4
 at low pH compared to neutral pH, which 
is in line with previous findings. Autoxidation of BH
4
 
proceeded more rapidly as pH was increased (Blair & 
Pearson, 1973; Pearson & Blair, 1975; Pearson, 1974). At 
high pH, this is due to deprotonation of the uncharged 
BH
4
 (pK
a
 10.5 (Blair & Pearson, 1973)) leading to a nega-
tively charged species that is easily oxidized. On the other 
hand, at lower pH singly (pK
a
 5.6 (Pfleiderer, 1982)) or 
even doubly charged species (pK
a
 1.3 (Pfleiderer, 1982)) 
are formed which are less susceptible toward oxidation. 
Thus, at pH <3 the rate was markedly reduced and at pH 
1–2 no degradation was observed during 20-min incuba-
tion (Lyudnikova et al., 2009). On the other hand, Howells 
and Hyland observed that 41 nM BH
4
 in 0.1 M HCl (pH 
around 1) was completely oxidized to BH
2
 and biopterin 
in 15 min (Howells & Hyland, 1987). Increasing the con-
centration to 415 nM meant that only 1.3% was oxidized 
in 15 min, and increasing the concentration even further 
led to an even lower percentage being oxidized (Howells 
& Hyland, 1987), showing that results at micromolar (in 
the study by Lyudnikova et al. a concentration of around 
0.1 mM was employed) and millimolar concentrations 
cannot be used to predict the behavior at the physiologi-
cally relevant nanomolar range.
At higher pH, the oxidation of BH
4
 is faster. The half-life 
of BH
4
can be estimated to be around half an hour at pH 3 
and at pH 4 and above almost complete oxidation takes 
place in 20 min (Lyudnikova et al., 2009). At pH 5.3–7.6 
the half-life was estimated to around 9 min (Heales et al., 
1988), and another study found half-lives of 6.5–60 min 
at pH 6.8–8.2 depending on the buffer used (Davis et al., 
1988). Similarly, a half-life of 15–20 min was observed at 
pH 7.4 (Valent & Tóth, 2006). Somewhat greater stability 
was found by Berka et al. (2004) who observed half-lives 
of 40 and 120 min at pH 7 and 3, respectively.
BH
4
, being more reduced than BH
2
, is more prone 
to oxidation than BH
2
, and an antioxidant is almost 
always used when handling samples containing BH
4
. 
Co-administration of antioxidants greatly enhances 
the stability of BH
4
. Our studies showed no significant 
degradation of BH
4
 in acid with either DTE or TCEP for 
48 h except for the combination TCA and DTE. Why BH
4
 
showed less stability in TCA with DTE than in the two 
other acids is not known. A previous study has shown 
that acid alone was not enough to stabilize BH
4
 at nano-
molar concentration (Howells & Hyland, 1987), whereas 
at micromolar concentration acid without antioxidant 
was sufficient to stabilize BH
4
, at least for 20 min (Howells 
& Hyland, 1987; Lyudnikova et al., 2009). Ascorbic acid 
(5.7 mM) prevented oxidation of 31 µM BH
4
 for 20 h and 
41.5 nM BH
4
 (both containing 0.1 M HCl) for 4 h when 
the solutions were gassed with argon (Howells & Hyland, 
1987). In another study, it was found that 100 nM BH
4
 at 
pH 7.4 was completely oxidized within 20 min and that 
100 µM ascorbic acid increased the half-life to around 
70 min (Heller et al., 2001). Berka et al. found that DTT 
was able to lower the decay rate fourfold at pH 7, and 
that DTE together with DETAPAC was able to increase 
the half-life by a factor of 6 at pH 3 (Berka et al., 2004). 
Another study found that 0.5 mM DTT inhibited the 
oxidation of BH
4
 at pH 7.4 by 85–90% (Valent & Tóth, 
2006). Other studies have found that 0.1% DTE or 0.1% 
DTT is able to stabilize BH
4
 for 2.5–5 h when a chelating 
agent such as EDTA is also used (Cañada-Cañada et al., 
2009; Espinosa-Mansilla et al., 2008; Powers et al., 1988; 
Howells et al., 1986). Our studies showed that degrada-
tion of BH
4
 at pH 7.4 begins immediately and that there is 
not a lag phase during which no degradation takes place 
(Figure 3), as other studies might indicate. However, 
with a rate constant of 0.25 nM h–1 in DTE only 1% of BH
4
 
would have degraded during the first hour.
The lower BH
4
 response with MPA remains unclear. It 
does not seem to be degradation as there is no change for 
50 h (Figure 2), but interference with the assay, i.e. oxida-
tion by iodine, cannot be ruled out.
Only few publications have reported on the stability of 
biopterins in blood samples. Fiege et al. studied the stabil-
ity of BH
4
 in blood samples stored at –80°C for 8 months. 
They found that without antioxidant all BH
4
 was oxidized 
and that DTE was better at stabilizing BH
4
 than ascorbate 
(Fiege et al., 2004). Another study examined the stability 
of BH
4
 in blood at room temperature (Fekkes & Voskuilen-
Kooijman, 2007). It was found that 0.1% DTT offered better 
protection than 0.5 and 0.25% DTT. It was also observed 
that centrifugation of the blood sample right after it had 
been collected gave a lower total biopterin level com-
pared to waiting for 3 h before centrifugation of the blood 
sample, and after 3 h the level of BH
4
 started to decline 
whereas the total biopterin level remained constant for 
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24 h (Fekkes & Voskuilen-Kooijman, 2007). Our results do 
not show a higher biopterin level if the blood sample is 
allowed to stand for 3 h prior to centrifugation. However, 
if the methodology by Fekkes and Voskuilen-Kooijman 
is correctly described in their paper, it appears that the 
authors did not stoichiometrically add enough iodine to 
oxidize the added DTT. This could explain their findings 
since enough of the DTT could have reacted after 3 hours 
to leave sufficient iodine to oxidize BH
4
 and BH
2
 and 
thereby give a higher response.
Some of the observations that were made in the BH
4
 
and BH
2
 model systems were also found in the blood 
samples whereas others were not. BH
2
 in model systems 
was degraded by acid whereas this did not seem to be 
the case in blood. The iodine oxidation method gives the 
total amount of BH
2
 and biopterin and if BH
2
 were con-
verted exclusively to biopterin, this would not affect the 
measured amount. However, the model studies with BH
2
 
clearly showed (Table 2) that BH
2
 is not only converted to 
biopterin but also to some unidentified species. Hence, 
if BH
2
 were degraded by acid in blood a lowering of the 
BH
2
 + biopterin level would have been expected. As this 
is not the case, protective factors such as endogenous 
ascorbate or EDTA coming from the blood sampling 
tubes are more likely to explain the findings. BH
4
 was 
found to degrade in model systems at pH 7.4 (Figure 3). 
This was not reproduced in blood samples. Even though 
degradation is slow (0.25 nM/h) about 1.5 nM, cor-
responding to 6%, would have degraded in 6 h which 
would have been detectable. As above, the most likely 
reason is the presence of stabilizing factors in the blood 
samples such as ascorbate and EDTA. One significant 
finding that was observed in both model systems and 
blood samples was the lower level of BH
4
 with MPA, 
which seemed to be even worse in blood samples than 
in the model systems, and the lower recovery of total 
biopterins in blood samples (Table 3) and the BH
2
 model 
system (Table 2). TCA provided the highest level of BH
4
 
and lowest level of BH
2
.
The reason for the differences in BH
4
 and BH
2
 levels 
observed with the three acids is not clear. The inverse 
relationship between BH
4
 and BH
2
 levels observed for 
the three acids (Table 3) could indicate different degrees 
of oxidation of BH
4
, i.e. most oxidation with MPA and 
least with TCA. However, levels of BH
4
 and BH
2
 did not 
change with time, which would have been expected if 
oxidation took place. Furthermore, the model studies 
showed that BH
4
 was not oxidized for 48 h in acid (with 
the exception of TCA with DTE). It therefore seems 
more likely that the acids interact differently with the 
iodine oxidation assay. MPA is unsuitable for biopterin 
analysis with the iodine oxidation assay, as the levels 
of BH
4
 are simply too low. Presumably, a higher BH
4
 
level reflects less post-sampling oxidation, which leaves 
TCA the better choice as the level of BH
4
 is significantly 
higher and the level of total biopterins the same com-
pared to PA (Table 3).
Comparing the different pretreatments of the samples, 
acid precipitation of the blood sample immediately after 
blood drawing seems to give the lowest level of BH
2
 and 
hence least oxidation (Table 4). However, the differences 
are small, albeit significant, and no method seems to be 
vastly superior to the others.
conclusions
The high stability of BH
4
 and degradation of BH
2
 in acid 
and vice versa at neutral pH poses an analytical challenge 
when using the combined measurement as a biomarker 
of endothelial function. However, we have shown that 
the levels of BH
2
+ biopterin and BH
4
 did not change with 
time for up to 6.5 h. TCA is the best choice for precipitat-
ing proteins whereas MPA should not be used. Whether 
plasma is separated and proteins precipitated imme-
diately or at a later stage only has a minor effect on the 
levels of biopterins determined.
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